Your browser doesn't support javascript.
loading
The impact of cytoreductive nephrectomy on survival outcomes in patients treated with tyrosine kinase inhibitors for metastatic renal cell carcinoma in a real-world cohort.
Janisch, Florian; Hillemacher, Tobias; Fuehner, Constantin; D'Andrea, David; Meyer, Christian P; Klotzbücher, Thomas; Kienapfel, Christina; Vetterlein, Malte W; Kimura, Shoji; Abufaraj, Mohammad; Dahlem, Roland; Shariat, Shahrokh F; Fisch, Margit; Rink, Michael.
Affiliation
  • Janisch F; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, Medical University of Vienna, Vienna, Austria.
  • Hillemacher T; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Fuehner C; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • D'Andrea D; Department of Urology, Medical University of Vienna, Vienna, Austria.
  • Meyer CP; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Klotzbücher T; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Kienapfel C; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Vetterlein MW; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Kimura S; Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Urology, Jikei University School of Medicine, Tokyo, Japan.
  • Abufaraj M; Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Special Surgery, Jordan University hospital, The University of Jordan, Amman, Jordan.
  • Dahlem R; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Shariat SF; Department of Urology, Medical University of Vienna, Vienna, Austria; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia; Department of Urology, Weill Cornell Medical School, New York, NY; Department of Urology, University of Texas Southwestern Medical Center, Dallas,
  • Fisch M; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Rink M; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: m.rink@uke.de.
Urol Oncol ; 38(9): 739.e9-739.e15, 2020 09.
Article in En | MEDLINE | ID: mdl-32576526
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Protein-Tyrosine Kinases / Carcinoma, Renal Cell / Protein Kinase Inhibitors / Cytoreduction Surgical Procedures / Sorafenib / Sunitinib / Kidney Neoplasms / Nephrectomy Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Language: En Journal: Urol Oncol Year: 2020 Type: Article Affiliation country: Austria
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Protein-Tyrosine Kinases / Carcinoma, Renal Cell / Protein Kinase Inhibitors / Cytoreduction Surgical Procedures / Sorafenib / Sunitinib / Kidney Neoplasms / Nephrectomy Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Language: En Journal: Urol Oncol Year: 2020 Type: Article Affiliation country: Austria